Literature DB >> 11911121

Effect of personality dimensions on the diurnal pattern of motor activity.

Anita C Volkers1, Joke H M Tulen, Hugo J Duivenvoorden, Marieke J Gieteling, Marlies Wegewijs-De Jong, Walter W Van Den Broek, Jan Passchier, Lolke Pepplinkhuizen.   

Abstract

The effects of personality dimensions, age, and gender on 24-hour motor activity patterns were studied in 101 healthy subjects between 20-70 years. We measured motor activity by wrist-actigraphy and personality dimensions by the Tridimensional Personality Questionnaire (TPQ) of Cloninger. Random Regression Models were used to estimate the effects of personality dimensions, age, and gender on the diurnal pattern of motor activity. Harm Avoidance as well as Reward Dependence influenced the overall level of motor activity, independent of age and gender. Subjects high on Harm Avoidance showed lower activity levels than subjects low on Harm Avoidance, whereas subjects high on Reward Dependence had higher overall levels of motor activity than subjects low on Reward Dependence. Older subjects were found to be less active than younger subjects, but the activity level did not differ between males and females.

Mesh:

Year:  2002        PMID: 11911121     DOI: 10.1111/1467-6494.05004

Source DB:  PubMed          Journal:  J Pers        ISSN: 0022-3506


  4 in total

1.  Harm avoidance and risk of Alzheimer's disease.

Authors:  Robert S Wilson; Patricia A Boyle; Aron S Buchman; Lei Yu; Steven E Arnold; David A Bennett
Journal:  Psychosom Med       Date:  2011-09-23       Impact factor: 4.312

2.  Harm avoidance and cerebral infarction.

Authors:  Robert S Wilson; Patricia A Boyle; Steven R Levine; Lei Yu; George M Hoganson; Aron S Buchman; Julie A Schneider; David A Bennett
Journal:  Neuropsychology       Date:  2013-12-23       Impact factor: 3.295

3.  Harm avoidance is associated with progression of parkinsonism in community-dwelling older adults: a prospective cohort study.

Authors:  Aron S Buchman; Lei Yu; Robert S Wilson; Joshua M Shulman; Patricia A Boyle; David A Bennett
Journal:  BMC Geriatr       Date:  2014-04-23       Impact factor: 3.921

4.  Measurement of Neuropsychiatric Symptoms in Clinical Trials Targeting Alzheimer's Disease and Related Disorders.

Authors:  Renaud David; Emmanuel Mulin; Patrick Mallea; Philippe H Robert
Journal:  Pharmaceuticals (Basel)       Date:  2010-07-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.